Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Changes in Peripheral CD4+CD25 high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Efficacy of different therapeutic modalities for patients with acute-on-chronic liver failure induced by hepatitis B

A High Frequency of CD8+CD28- T-suppressor Cells Contributes to Maintaining Stable Graft Function and Reducing Immunosuppressant Dosage after Liver Transplantation

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

Expression of Circulating CD4+ CD25+ Foxp3+ Regulatory T Cells in Liver Allograft Recipients with Acute Rejection

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Study on the value of Foxp3 + Tregs level in peripheral blood of patients with relapsed and refractory acute lymphoblastic leukemia after CAR-T cell therapy

Analysis of NK/T and Treg cell in peripheral blood of patients with different malignancies during the chemotherapy

Clinical Evaluation of Treatment with Artificial Liver Support System in Chronic Fulminant Viral Hepatitis

Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases

The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients

Peripheral Blood Immune Cells in Long-Term Survival Patients after Liver Transplantation

Effects of Regulatory T Cells on Anti-Viral Immune Responses Impaired by Chronic Hepatitis B

The Clinical Relationship Between Presence of Peripheral Blood Regulatory T Cells and Hepatocellular Carcinoma and the Influence of Liver Resection on the Presence of Regulatory T Cells

Expression and significance of CD39 on regulatory T cells in the peripheral blood of patients following liver transplantation

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B

Dynamic Changes of Cellular Immune Function and Individualized Adjustments of Immunosuppressant for the Management of Severe Infection after Liver Transplantation

[The Frequency, Phenotypes and Functions of CD4+ CD25+ Regulatory T Cells in Hepatocellular Carcinoma Patients].

Regulatory T Cells Contribute to the Immunoregulatory Effect on Graft Versus Host Reaction after Liver Transplantation in Donor-Dominant One-Way Mhc Matching Rats